** Short interest in women's contraception company Evofem
Biosciences EVFM.O climbed sharply after the U.S. Supreme
Court struck down Roe v. Wade in June, said S&P Global Market
Intelligence
** Short interest in healthcare sector hit 4.32% at the end
of June, and it was the second most-shorted sector - S&P Global
** Evofem Biosciences was one of the most shorted company at
the end of the month topping 50%, analytics co said
** Retail investors have flocked to small biotech firms that
make women contraceptives after the Supreme Court decision
urn:newsml:reuters.com:*:nL4N2YI2N3
** Evofem sells a non-hormonal contraception gel called
Phexxi
(Reporting by Mrinalika Roy in Bengaluru)
((mrinalika.roy@thomsonreuters.com;))